Joint Gummy
Natural health product licensed in Canada
- Licence holder
- Jamieson Laboratories Ltd./ Nutricorp International
- NPN or DIN-HM
- 80053963
- Status
- Active licence
- Licence date
- 17 September 2014
- Revision date
- Not provided
- Form
- Bloc
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 3,3'-dihydroxy-4,4'-diketo-bêta-carotène Source : Haematococcus pluvialis - whole | 333 mcg | Not calculated |
| Riboflavine Source : Riboflavine | 83 mcg | Not calculated |
| Membrane de coquille d'oeuf de poule partiellement hydrolysée Source : Gallus gallus - Coquille d'oeuf | 83.3 mg | Not calculated |
| Membrane de coquille d'oeuf de poule partiellement hydrolysée Source : Partially hydrolysed chicken eggshell membrane | 83.3 mg | Not calculated |
| Boswellia serrata Source : Stem bark oleogum resin Extraction ratio : 14:1 Dry plant equivalent : 116.2 mg Potency : 40 % Boswellic acid | 8.3 mg | Not calculated |
| Acide hyaluronique Source : Gallus gallus - Crête | 10 mg | Not calculated |
| Acide hyaluronique Source : Hyaluronate de sodium | 10 mg | Not calculated |
Non-medicinal ingredients
Saveur de cerise, Huile de noix de coco, Jus de carotte, Rebaudioside A, Cire d'abeille, Acid citrique, Jus de grosseillier noir, Riboflavine, Cire de Carnauba, oligofructose, Huile végétale, Inuline, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 6 Bloc(s) | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps reduce pain associated with osteoarthritis. Helps to reduce stiffness associated with osteoarthritis. Helps to relieve joint pain associated with osteoarthritis. Helps to relieve pain associated with osteoarthritis of the knee. Helps to reduce joint pain associated with osteoarthritis. Helps to reduce stiffness associated with osteoarthritis. Helps to relieve joint pain and stiffness associated with osteoarthritis. Helps to reduce blood C reactive protein levels, a clinical marker of inflammation. Starts to help reduce pain at 5 days.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80053963
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.